Clinical Trial Update: COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction [Phase 2, Phase 3]

View source ↗

Summary

Trial update indicates the colchicine study aiming to prevent sympathetic denervation after an acute myocardial infarction (Phase 2/Phase 3) has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction Acute

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Myocardial Infarction, Acute | Phase 2, Phase 3 | Status: TERMINATED